Hongli Yin

Suzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Virtual screening and MD simulation-guided discovery of CDK12-IN-3, a potent ALK inhibitor suppressing neuroblastoma growth in vitro and in vivo.

Virtual screening and MD simulation-guided discovery of CDK12-IN-3, a potent ALK inhibitor suppressing neuroblastoma growth in vitro and in vivo.

Journal: Frontiers in chemistry

Published: May 01, 2026

The MYC network: Hub of malignancy and blueprint for intervention.

The MYC network: Hub of malignancy and blueprint for intervention.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: March 16, 2026

An Integrated Transcriptional and Post-Transcriptional Regulatory Circuit Orchestrated by NUDT21 Maintains the Proliferation and Survival of Neuroblastoma.

An Integrated Transcriptional and Post-Transcriptional Regulatory Circuit Orchestrated by NUDT21 Maintains the Proliferation and Survival of Neuroblastoma.

Journal: Neuro-oncology

Published: December 26, 2025

NeuroD1-USP1-MYCN axis drives tumor progression in neuroblastoma.

NeuroD1-USP1-MYCN axis drives tumor progression in neuroblastoma.

Journal: Journal of translational medicine

Published: October 07, 2025

KIF11 promotes AML progression, and its inhibition by SB-743921 suppresses disease advancement through mitotic G2/M phase arrest.

KIF11 promotes AML progression, and its inhibition by SB-743921 suppresses disease advancement through mitotic G2/M phase arrest.

Journal: Cellular signalling

Published: June 03, 2025

Identification of novel AURKA inhibitors against neuroblastoma using a virtual screening approach.

Identification of novel AURKA inhibitors against neuroblastoma using a virtual screening approach.

Journal: Bioorganic chemistry

Published: March 18, 2025

Core transcriptional regulatory circuit-regulated IGF2BP3 stabilizes E2F2 mRNA via m6A modification in neuroblastoma.

Core transcriptional regulatory circuit-regulated IGF2BP3 stabilizes E2F2 mRNA via m6A modification in neuroblastoma.

Journal: Carcinogenesis

Published: December 31, 2024

Exploring FAM13A-N-Myc interactions to uncover potential targets in MYCN-amplified neuroblastoma: a study of protein interactions and molecular dynamics simulations.

Exploring FAM13A-N-Myc interactions to uncover potential targets in MYCN-amplified neuroblastoma: a study of protein interactions and molecular dynamics simulations.

Journal: BMC cancer

Published: November 14, 2024

USP20 as a super-enhancer-regulated gene drives T-ALL progression via HIF1A deubiquitination.

USP20 as a super-enhancer-regulated gene drives T-ALL progression via HIF1A deubiquitination.

Journal: Acta pharmaceutica Sinica. B

Published: November 12, 2024

Super-Enhancer-Driven IRF2BP2 is Activated by Master Transcription Factors and Sustains T-ALL Cell Growth and Survival.

Super-Enhancer-Driven IRF2BP2 is Activated by Master Transcription Factors and Sustains T-ALL Cell Growth and Survival.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 25, 2024

Super-enhancer-driven IRF2BP2 enhances ALK activity and promotes neuroblastoma cell proliferation.

Super-enhancer-driven IRF2BP2 enhances ALK activity and promotes neuroblastoma cell proliferation.

Journal: Neuro-oncology

Published: June 12, 2024

Targeting RBM39 through indisulam induced mis-splicing of mRNA to exert anti-cancer effects in T-cell acute lymphoblastic leukemia.

Targeting RBM39 through indisulam induced mis-splicing of mRNA to exert anti-cancer effects in T-cell acute lymphoblastic leukemia.

Journal: Journal of experimental & clinical cancer research : CR

Published: April 24, 2024

Showing 1-12 of 24

Last Updated: 09/26/2026